期刊文献+

降低聚乙烯吡咯烷酮浓度对卵胞浆内单精子显微注射效果的影响 被引量:4

Effect of a decreased polyvinylpyrrolidone concentration on the outcome of intracytoplasmic sperm injection
下载PDF
导出
摘要 目的:探讨卵胞浆内单精子注射(ICSI)操作中,降低聚乙烯吡咯烷酮(PVP)浓度对ICSI效果的影响。方法:将132例160个周期接受ICSI治疗的患者所获1549个MⅡ卵随机1∶1分配,分别采用在含7%和3.5%PVP(对有A、B级活动精子的周期)或者在3.5%和不含PVP(对仅有C、D级活动精子的周期)操作液中制动的精子行ICSI,比较ICSI效果。结果:PVP浓度为3.5%时,ICSI卵的受精率和卵裂率分别为80.12%和96.78%,与PVP浓度为7%时的受精率(79.84%)和卵裂率(96.89%)比较差异无显著性(P>0.05),但采用3.5%PVP制动精子行ICSI获得的优质胚胎率达77.76%,高于7%PVP制动时的71.43%,差异有显著性(P<0.05)。在不含PVP操作液中制动精子后行ICSI,卵子的受精率、卵裂率及优质胚胎率均与在3.5%PVP制动精子行ICSI差异无显著性(P>0.05)。结论:对于活动力良好的精子,降低精子制动液的PVP浓度至3.5%,可提高ICSI的优质胚胎率。精子活动力差时,进一步降低PVP浓度对ICSI效果无明显影响。 Objective To explore whether a decrease of polyvinylpyrrolidone (PVP) concentration will affect the outcome of ICSI. Methods 1 549 M II oocytes harvested from 160 cycles of 132 infertile women were randomized in a 1:1 ratio to receive ICSI with the spermatozoa that had been immobilized either in 7% or 3.5% of PVP solution (for the cycles with good sperm mobility) or in 3.5% of PVP or PVP-free solution (for the cycles with poor sperm mobility). The impacts of PVP at different concentrations on ICSI were compared. Results The rate of good-quality embryo differed significantly as the PVP concentration was 3.5% or 7% (77.76% vs 71.43%, P〈 0.05) whereas the fertilization rate and cleavage rate did not (80.12% vs 79.84% and 96.78% vs 96.89%, respectively, P 〉 0.05). There were no significant differences in the rates of fertilization, cleavage, and good-quality embryo under the conditions of 3.5% of PVP or PVP-free solution (P 〉 0.05). Conclusions For spermatozoa with good mobility, to decrease the PVP concentration to 3.5% may enhance the rate of good quality-embryo. A further decline in the PVP concentration, however, dose not affect the outcome of ICSI when spermatozoa have poor mobility.
出处 《实用医学杂志》 CAS 北大核心 2009年第1期68-70,共3页 The Journal of Practical Medicine
关键词 受精 体外 胚胎移植 精子制动 聚乙烯吡咯烷酮 Fertilization in vitro Embryo transfer Sperm immobilization Polyvinylpyrrolidone
  • 相关文献

参考文献7

  • 1Gerris J, Mangelschots K, Van Royen E, et al. ICSI and severe male-factor infertility: breaking the sperm tail prior to injection [J]. Hum Reprod, 1995,10(2) :484-486.
  • 2Jean M, Mirallie S, Bourdineau M, et al. Intracytoplasmic sperm injection with polyvinylpyrrolidone: a potential risk [J]. Fertil. Steril, 2001,76(2) :419-420.
  • 3Mizuno K, Hoshi K, Huang T. Fertilization and embryo development in a mouse ICSI model using human and mouse sperm after immobilisation in polyvinlypyrrolidone [J]. Hum Reprod, 2002,17 (9) :2350-2355.
  • 4Veeck L L. The morphological assessment of human oocytes and early concpti [ M ]//Keel B A, Webster B W. Handbook of the laboratory diagnosis and treatment of infertility. Boca Raton, Fla: CRC Press, 1990: 353.
  • 5赵晓娥,武浩,王勇胜,刘凤军,鲁进,张涌.山羊卵母细胞的显微受精[J].西北农林科技大学学报(自然科学版),2005,33(4):9-12. 被引量:5
  • 6Wei H, Yutaka F. Technical improvement in Intracytoplasmic sperm injection (ICSI) in cattle [J]. J Reprod Dev, 2000,46(3):403- 407.
  • 7黄仲英,李尚为,马黔红,李蕾,靳松.精子活动力对卵胞浆内单精子注射结局的影响[J].生殖与避孕,2006,26(1):47-50. 被引量:8

二级参考文献22

  • 1Xia P.Intracytoplasmic sperm injection: correlation of ooocytegrade based on polar body, perivitelline space and cytoplasmic inclusions with fertilization rate and embryo quality.Hum Reprod, 1997, 12(8):1750-5.
  • 2Ebner T, Moser M,Yaman C, et al. Elective embryo transfer selected on the basis of first polar body morphology is associated with increased rates of implantation and pregnancy.Fertil Steril, 1999, 72(4):599-603.
  • 3Ebner T, Yaman C,Moser M, et al. Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod,2000, 15(2): 427-30.
  • 4Ebner T, Moser M, Sommergruber M, et al. First polar body morphology and blastocyst formation rate in ICSI patients.Hum Reprod, 2002, 17(9): 2415-8.
  • 5Plachot M, Selva J, Wolf JP, et al. Consequences of oocyte dysmorphy on the fertilization rate and embryo development after intracytoplasmic sperm injection. A prospective multicenter study. Gynecol Obstet Fertil, 2002, 30(10): 772-9.
  • 6Hewitson LC, Simerly CR, Tengowski MW, et al. Microtubule and chromatin configurations during rhesus intracytoplasmic sperm injection:successes and failures.Biol Reprod,1996, 55(2):271-80.
  • 7Evirgen O, Ozguner M, Demirel LC, et al, Ultrastructural analysis of TESE and semen sperm tails from patients exhibiting absolute immotility on the day of ICSI. Arch Androl,2003, 49(1):57-67.
  • 8Friedler S, Raziel A,Strassburger, et al. Factors influencing the outcome of ICSI in patients with obstructive and non-obstructive azoospermia:a comparative study. Hum Reprod,2002, 17(12): 3114-21.
  • 9Anne LM & Svend L. Morphology of in-vitro matured oocytes:impact on fertility potential and embryo quality.Hum Reprod, 2001,16(8):1714-8.
  • 10Sallam HN,Farrag A, Agameya AF, et al.The use of a modified hypo-osmotic swelling test for the selection of viable ejaculated and testicular immotile spermatozoa in ICSI. Hum Reprod, 2001,16(2):272-6.

共引文献11

同被引文献40

  • 1王君,赵红丹,张朝红,张邯玉,熊大珍,张向东,孙伟,栗荣贺.二氧化钛催化超声波损伤牛血清白蛋白的研究[J].无机化学学报,2007,23(3):439-444. 被引量:6
  • 2Fleming R, Hopkinson ZE, Wallace AM, et al. Ovarian function and metabolicfaetors in women with oligomenorrhea treated with mefformin in a randomized double blind placebo-controlled trlal[ J ]. J Clin En- docrinol Metab,2002, 87:569-574.
  • 3Hammadeh ME, Fischer-Hammadeh C, Amer AS, et al. Relationship between cytokine concentration in serum and preovulatory follicular flu- id and in vitro fertilization/intracytoplasmic sperm injection outcome [ J]. Chem Immunol Allergy,2005,88:80-97.
  • 4Cerkiene Z1, Eidukaite A, Usoniene A. Follicular fluid levels of inter-leukin-10 and interferon-gamma do not predict outcome of assisted re- productive technologies [ J ]. Am J Reprod Immunol, 2008, 59 (2) :1/8-126.
  • 5He H, Li T, Yin D, et al. HOXA10 expression is decreased by testos- terone in luteinized granulosa cells in vitro [ J ]. M ol Med Rep ,2012,6 ( 1 ) :51-56.
  • 6Juengel JL, McNatty KP. The role of proteins of the transforming growth factor-beta superfamily in the intraovarian regulation of follicular development[ J]. Hum Reprod Update ,2005,11 ( 2 ) : 1434-60.
  • 7Yao G, Yin M, Lian J, et al. MicroRNA-224 is involved in transfor- ming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targetinS Smad4 [ J ]. Mol Endocrinol, 2010,24(3) :540-551.
  • 8Rotterdam ESHRFJASRM-Sponsered PCOS Consensus Workshop Group. Revised 20173 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod,2004,19 ( 1 ) :41-47.
  • 9Ingman WV, Robertson SA. The essential roles of TGFB1 in reproduc- tion [ J ]. Cytokine Growth Factor Rev,2009,20:233-239.
  • 10Mulheron GW, Bossert NL, Lapp JA, et al. Human granulosa-luteal and cumulus cells express transforming growth factors-beta type 1 and type 2 mRNA [ J ]. J Clin Endocrinol Metab, 1992,74:458-460.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部